Ziehm Imaging and BrainLAB have extended their development and marketing agreement for the integration of Ziehm’s mobile 3D C-arms and BrainLAB’s computer-assisted surgical systems (CAS).
Ziehm Imaging and BrainLAB have extended their development and marketing agreement for the integration of Ziehm's mobile 3D C-arms and BrainLAB's computer-assisted surgical systems (CAS). The new agreement extends the combination of CAS and C-arms from Europe to North America. The partnership goes back to 2002, when the two companies collaborated on the development of DICOM-based CAS on 2D fluoroscopic images. In 2007, the companies combined the Ziehm C-arm Vision2 Vario 3D with all mobile BrainLAB platforms for 3D intraoperative imaging in Europe. The Ziehm Vision2 Vario 3D allows surgeons to obtain a volumetric 3D data set and display sagittal, coronal, and axial views intraoperatively.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.